The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression

Scientific Reports

Volumn 6, Issue , 2016, Pages

  De Bruin, Ruben G ^a   Van Der Veer, Eric P ^a   Prins, Jurriën ^a   Lee, Dae Hyun ^a   Dane, Martijn J C ^a   Zhang, Huayu ^a   Roeten, Marko K ^a   Bijkerk, Roel ^a   De Boer, Hetty C ^a   Rabelink, Ton J ^a   Van Zonneveld, Anton Jan ^a   Van Gils, Janine M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; LEUKOCYTE ANTIGEN; MESSENGER RNA; PROTEIN BINDING; QKI PROTEIN, HUMAN; RNA BINDING PROTEIN; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; FEMALE; GENE EXPRESSION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTIGENS, CD; BETA CATENIN; CADHERINS; CAPILLARY PERMEABILITY; FEMALE; GENE EXPRESSION; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEIN BINDING; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84959264209     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21643     Document Type: Article

References (60)

1. Deanfield, J. E., Halcox, J. P. & Rabelink, T. J. Endothelial function and dysfunction testing and clinical relevance. Circulation 115, 1285-1295 (2007).
2. Dejana, E., Tournier-Lasserve, E. & Weinstein, B. M. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 16, 209-221 (2009).
3. Wallez, Y. & Huber, P. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778, 794-809 (2008).
4. Vestweber, D., Winderlich, M., Cagna, G. & Nottebaum, A. F. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 19, 8-15 (2009).
5. Chamorro-Jorganes, A., Araldi, E. & Suarez, Y. MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. Pharmacol Res 75, 15-27 (2013).
6. Reijerkerk, A. et al. MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis. J Neurosci 33, 6857-6863 (2013).
7. Pepini, T., Gorbunova, E. E., Gavrilovskaya, I. N., Mackow, J. E. & Mackow, E. R. Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability. J Virol 84, 11929-11936 (2010).
8. Uchida, S. & Dimmeler, S. Long noncoding RNAs in cardiovascular diseases. Circ Res 116, 737-750 (2015).
9. Li, K. et al. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 115, 133-139 (2010).
10. Yan, B. et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res 116, 1143-1156 (2015).
11. Keene, J. D. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8, 533-543 (2007).
12. Eom, T., Antar, L. N., Singer, R. H. & Bassell, G. J. Localization of a beta-actin messenger ribonucleoprotein complex with zipcodebinding protein modulates the density of dendritic filopodia and filopodial synapses. J Neurosci 23, 10433-10444 (2003).
13. Ray, D. et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature 499, 172-177 (2013).
14. Vumbaca, F., Phoenix, K. N., Rodriguez-Pinto, D., Han, D. K. & Claffey, K. P. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol Cell Biol 28, 772-783 (2008).
15. Blanco, F. J. & Bernabeu, C. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence. Aging Cell 10, 896-907 (2011).
16. Ceolotto, G. et al. Sirtuin 1 stabilization by HuR represses TNF-alpha- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome. Clin Sci (Lond) 127, 449-461 (2014).
17. Bohnsack, B. L., Lai, L., Northrop, J. L., Justice, M. J. & Hirschi, K. K. Visceral endoderm function is regulated by quaking and required for vascular development. Genesis. 44, 93-104 (2006).
18. Noveroske, J. K. et al. Quaking is essential for blood vessel development. Genesis. 32, 218-230 (2002).
19. van Mil, A. et al. MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 93, 655-665 (2012).
20. Chenard, C. A. & Richard, S. New implications for the QUAKING RNA binding protein in human disease. J. Neurosci. Res. 86, 233-242 (2008).
21. Kondo, T. et al. Genomic organization and expression analysis of the mouse qkI locus. Mamm. Genome 10, 662-669 (1999).
22. Conn, S. J. et al. The RNA binding protein quaking regulates formation of circRNAs. Cell 160, 1125-1134 (2015).
23. Hall, M. P. et al. Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. RNA 19, 627-638 (2013).
24. Larocque, D. et al. Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nat Neurosci 8, 27-33 (2005).
25. Saccomanno, L. et al. The STAR protein QKI-6 is a translational repressor. Proc Natl Acad Sci USA 96, 12605-12610 (1999).
26. Wang, Y. et al. The QKI-RNA binding protein localizes with the MBP mRNAs in stress granules of glial cells. PLoS One 5, e12824 (2010).
27. van der Veer, E. P. et al. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype. Circ. Res. 113, 1065-1075 (2013).
28. Wang, Y., Vogel, G., Yu, Z. & Richard, S. The QKI-5 and QKI-6 RNA binding proteins regulate the expression of microRNA 7 in glial cells. Mol. Cell Biol. 33, 1233-1243 (2013).
29. Wu, J., Zhou, L., Tonissen, K., Tee, R. & Artzt, K. The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm. J Biol Chem 274, 29202-29210 (1999).
30. Frueh, J. et al. Systems biology of the functional and dysfunctional endothelium. Cardiovasc Res 99, 334-341 (2013).
31. Dekker, R. J. et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 100, 1689-1698 (2002).
32. Uematsu, M. et al. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol 269, C1371-1378 (1995).
33. Anderson, K. P., Kern, C. B., Crable, S. C. & Lingrel, J. B. Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Kruppel-like factor: identification of a new multigene family. Mol. Cell Biol. 15, 5957-5965 (1995).
34. Dekker, R. J. et al. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 107, 4354-4363 (2006).
35. Sen Banerjee, S. et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199, 1305-1315 (2004).
36. Tiruppathi, C., Malik, A. B., Del Vecchio, P. J., Keese, C. R. & Giaever, I. Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc. Natl. Acad. Sci. USA 89, 7919-7923 (1992).
37. Giaever, I. & Keese, C. R. Micromotion of mammalian cells measured electrically. Proc. Natl. Acad. Sci. USA 88, 7896-7900 (1991).
38. Szulcek, R., Bogaard, H. J. & van Nieuw Amerongen, G. P. Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility. J Vis Exp 85, e51300 (2014).
39. Galarneau, A. & Richard, S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat. Struct. Mol. Biol. 12, 691-698 (2005).
40. Hafner, M. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129-141 (2010).
41. Kaplan, A. P. & Ghebrehiwet, B. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol 47, 2161-2169 (2010).
42. Orsenigo, F. et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3, 1208 (2012).
43. Figini, M. et al. Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol 272, G785-793 (1997).
44. Li, Z., Zhang, Y., Li, D. & Feng, Y. Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci 20, 4944-4953 (2000).
45. Zearfoss, N. R., Clingman, C. C., Farley, B. M., McCoig, L. M. & Ryder, S. P. Quaking regulates Hnrnpa1 expression through its 3′ UTR in oligodendrocyte precursor cells. PLoS Genet 7, e1001269 (2011).
46. Yu, F. et al. Post-transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells. Oncol Rep 31, 1459-1465 (2014).
47. Yang, G. et al. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 138, 231-240 e231-235 (2010).
48. Ji, S. et al. miR-574-5p negatively regulates Qki6/7 to impact beta-catenin/Wnt signalling and the development of colorectal cancer. Gut 62, 716-726 (2013).
49. Ciais, D., Cherradi, N. & Feige, J. J. Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation. Cell Mol Life Sci 70, 2031-2044 (2013).
50. Berkovits, B. D. & Mayr, C. Alternative 3′ UTRs act as scaffolds to regulate membrane protein localization. Nature 522, 363-367 (2015).
51. Pullmann, R., Jr. & Rabb, H. HuR and other turnover- and translation-regulatory RNA-binding proteins: implications for the kidney. Am J Physiol Renal Physiol 306, F569-576 (2014).
52. Beuck, C., Qu, S., Fagg, W. S., Ares, M., Jr. & Williamson, J. R. Structural analysis of the quaking homodimerization interface. J Mol Biol 423, 766-781 (2012).
53. Ali, M. & Broadhurst, R. W. Solution Structure of the QUA1 Dimerization Domain of pXqua, the Xenopus Ortholog of Quaking. PloS one 8, e57345 (2013).
54. Larocque, D. et al. Nuclear retention of MBP mRNAs in the quaking viable mice. Neuron 36, 815-829 (2002).
55. Seebach, J. et al. Endothelial barrier function under laminar fluid shear stress. Laboratory investigation 80, 1819-1831 (2000).
56. Redmond, L. C. et al. Kruppel-like factor 2 regulated gene expression in mouse embryonic yolk sac erythroid cells. Blood Cells Mol. Dis. 47, 1-11 (2011).
57. Hergenreider, E. et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14, 249-256 (2012).
58. Artzt, K. & Wu, J. I. STAR trek: An introduction to STAR family proteins and review of quaking (QKI). Advances in experimental medicine and biology 693, 1-24 (2010).
59. Ebersole, T. A., Chen, Q., Justice, M. J. & Artzt, K. The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat. Genet. 12, 260-265 (1996).
60. Sidman, R. L., Dickie, M. M. & Appel, S. H. Mutant Mice (Quaking and Jimpy) with Deficient Myelination in the Central Nervous System. Science 144, 309-311 (1964).